Competing risks data analysis, time-to-event data analysis, design of clinical trials with special emphasis on hematopoietic stem cell transplantation and cancer vaccine studies, missing data analysis, and high throughput data analysis.
Dr. Kim’s research involves the design, conduct, analysis and reporting of translational clinical trials, database and laboratory studies pertaining to hematopoietic stem cell transplantation (HSCT) and cancer vaccine projects at Dana-Farber/Harvard Cancer Center (DF/HCC), as well as leukemia-related translational clinical and laboratory studies conducted outside of DF/HCC.
Her statistical research focuses on statistical issues of competing risks data, time-to-event data, designing clinical trials with special emphasis on stem cell transplantation and cancer vaccine studies, missing data analysis, and high throughput data analysis.